Showing results (201-210 of 252) with videos related to

Sort By:
Pageof 26
Oncotarget|April 9, 2016
Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancerPietro Di Fazio, Petra Waldegger, Samir Jabari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPIThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Leukemia & Lymphoma|May 7, 2014
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeuticsThomas Melchardt, Lukas Weiss, Clemens Hufnagl, et al.
Cancer Research|October 16, 2003
Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbitsThaddäus Till Wissniowski, Johannes Hänsler, Daniel Neureiter, et al.
Cancers|November 26, 2022
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant TherapyFalk Roeder, Sabine Gerum, Stefan Hecht, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Histopathology|January 29, 2019
Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasisWiebke Solass, Christine Sempoux, Norman J Carr, et al.
British Journal of Haematology|September 20, 2014
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulinThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Anticancer Research|February 28, 2023
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck CancerSandro M Wagner, Teresa Magnes, Thomas Melchardt, et al.
International Journal of Cancer|October 22, 2017
Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistanceWolfgang Gruber, Elisabeth Peer, Dominik P Elmer, et al.
Pageof 26